Publications

Publications

Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.

Filter

All years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008
All product lines Easy Easy PGX Helix Microsatelliti Myriapod Myriapod NGS Realquant Response

Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics. Oncotarget

  • Myriapod

KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: observational analysis of 175 cases. Pathology

  • Response

RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study. Oncology Letters

  • Response

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer. The Oncologist

  • Response

HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping? Anticancer Research

Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules. Cancer Cytopathology

Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). Journal of Oncology

  • Response

Cangi MG, Biavasco R, Cavalli G, et al BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease Annals of the Rheumatic Diseases 2015;74:1596-1602.

  • Myriapod

Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: case report with genetic and epigenetic analyses. BMC Cancer

  • Response

“The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma,” Disease Markers, vol. 2015, Article ID 604719, 6 pages, 2015. doi:10.1155/2015/604719

Your next step starts here. Fill out the form and talk to us

Let's talk